PMID- 15504951 OWN - NLM STAT- MEDLINE DCOM- 20051107 LR - 20131121 IS - 1530-6860 (Electronic) IS - 0892-6638 (Linking) VI - 19 IP - 1 DP - 2005 Jan TI - Purinergic inhibition of the epithelial Na+ transport via hydrolysis of PIP2. PG - 142-3 AB - Stimulation of purinergic receptors inhibits amiloride-sensitive Na+ transport in epithelial tissues by an unknown mechanism. Because previous studies excluded the role of intracellular Ca2+ or protein kinase C, we examined whether purinergic regulation of Na+ absorption occurs via hydrolysis of phospholipid such as phosphatidylinositol-bisphosphates (PIP2). Inhibition of amiloride-sensitive short-circuit currents (Isc-Amil) by adenine 5'-triphosphate (ATP) in native tracheal epithelia and M1 collecting duct cells was suppressed by binding neomycin to PIP2, and recovery from ATP inhibition was abolished by blocking phosphatidylinositol-4-kinase or diacylglycerol kinase. Stimulation by ATP depleted PIP2 from apical membranes, and PIP2 co-immunoprecipitated the beta subunit of ENaC. ENaC was inhibited by ATP stimulation of P2Y2 receptors in Xenopus oocytes. Mutations in the PIP2 binding domain of betaENaC but not gammaENaC reduced ENaC currents without affecting surface expression. Collectively, these data supply evidence for a novel and physiologically relevant regulation of ENaC in epithelial tissues. Although surface expression is controlled by its C terminus, N-terminal binding of betaENaC to PIP2 determines channel activity. FAU - Kunzelmann, K AU - Kunzelmann K AD - Institut fur Physiologie, Universitat Regensburg, Universitatsstrasse 31, Regensburg, Germany. FAU - Bachhuber, T AU - Bachhuber T FAU - Regeer, R AU - Regeer R FAU - Markovich, D AU - Markovich D FAU - Sun, J AU - Sun J FAU - Schreiber, R AU - Schreiber R LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20041025 PL - United States TA - FASEB J JT - FASEB journal : official publication of the Federation of American Societies for Experimental Biology JID - 8804484 RN - 0 (Epithelial Sodium Channels) RN - 0 (P2ry2 protein, mouse) RN - 0 (Peptides) RN - 0 (Phosphatidylinositol 4,5-Diphosphate) RN - 0 (Receptors, Purinergic) RN - 0 (Receptors, Purinergic P2) RN - 0 (Receptors, Purinergic P2Y2) RN - 0 (Sodium Channel Blockers) RN - 0 (Sodium Channels) RN - 8L70Q75FXE (Adenosine Triphosphate) SB - IM MH - Adenosine Triphosphate/*pharmacology MH - Animals MH - Cells, Cultured MH - Epithelial Cells/chemistry/metabolism MH - Epithelial Sodium Channels MH - Hydrolysis MH - Kidney Tubules, Collecting/chemistry/cytology/metabolism MH - Mice MH - Oocytes/chemistry/metabolism MH - Patch-Clamp Techniques/methods MH - Peptides/metabolism MH - Phosphatidylinositol 4,5-Diphosphate/*metabolism MH - Protein Binding MH - Protein Structure, Tertiary MH - Receptors, Purinergic/metabolism MH - Receptors, Purinergic P2 MH - Receptors, Purinergic P2Y2 MH - Sodium Channel Blockers/*pharmacology MH - Sodium Channels/biosynthesis/*metabolism MH - Trachea/chemistry/metabolism MH - Xenopus EDAT- 2004/10/27 09:00 MHDA- 2005/11/08 09:00 CRDT- 2004/10/27 09:00 PHST- 2004/10/27 09:00 [pubmed] PHST- 2005/11/08 09:00 [medline] PHST- 2004/10/27 09:00 [entrez] AID - 04-2314fje [pii] AID - 10.1096/fj.04-2314fje [doi] PST - ppublish SO - FASEB J. 2005 Jan;19(1):142-3. doi: 10.1096/fj.04-2314fje. Epub 2004 Oct 25.